Endovia Health Sciences (EDVA) Property, Plant & Equipment (Net) Growth (3y) (2016 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Property, Plant & Equipment (Net) Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.06 Bn | 133.21 Bn | 2.84 Bn | 14.05% |
| 2 | Regeneron Pharmaceuticals | 86.96 Bn | 78.97 Bn | 3.93 Bn | 11.65% |
| 3 | Argenx Se | 64.93 Bn | 59.74 Bn | 1.37 Bn | 411.50% |
| 4 | Moderna | 57.22 Bn | 52.08 Bn | 52.00 Mn | -3.34% |
| 5 | Revolution Medicines | 44.59 Bn | 44.59 Bn | - | - |
| 6 | BeOne Medicines | 40.43 Bn | 35.33 Bn | 1.53 Bn | 16.78% |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 1.66% |
| 8 | Royalty Pharma | 28.17 Bn | 27.34 Bn | - | - |
| 9 | Insmed | 27.60 Bn | 26.43 Bn | 358.27 Mn | 19.96% |
| 10 | Endovia Health Sciences | 821,701.01 | 578,999.01 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -71.56% |
| Dec 31, 2025 | -70.22% |
| Sep 30, 2025 | -44.78% |
| Jun 30, 2025 | -36.43% |
| Mar 31, 2025 | -32.37% |
| Dec 31, 2024 | -66.09% |
| Sep 30, 2024 | -24.49% |
| Jun 30, 2024 | -23.04% |
| Mar 31, 2024 | -21.30% |
| Dec 31, 2023 | -19.93% |
| Sep 30, 2023 | 86.78% |
| Jun 30, 2023 | 87.53% |
| Mar 31, 2023 | 83.94% |
| Dec 31, 2022 | 134.99% |
| Sep 30, 2022 | 136.06% |
| Jun 30, 2022 | 125.50% |
| Mar 31, 2022 | 122.72% |
| Dec 31, 2021 | 113.40% |
| Sep 30, 2021 | 134.26% |
| Jun 30, 2021 | 145.03% |